Literature DB >> 3831015

Nicardipine releases sustained coronary arterial constriction induced by acetylcholine in the rhesus monkey.

K Satoh, M Kawada, Y Wada, N Taira.   

Abstract

In five rhesus monkeys (Macaca mulatta) the vascular bed of the left anterior descending coronary artery (LAD) was perfused at constant pressure with autologous blood. Nicardipine (1-30 micrograms), a dihydropyridine calcium antagonist when injected into the LAD, increased LAD flow without producing significant changes in other cardiohemodynamic variables. With continuous infusions of acetylcholine into the LAD, the flow decreased by about 34% of the basal value. Under these conditions, intra-LAD nicardipine produced an increase in LAD flow almost to the same extent as in the control. The effects of nicardipine were qualitatively similar to those of other calcium antagonists observed in previous experiments and indicate that nicardipine would be useful as an antianginal drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3831015     DOI: 10.1007/bf02066352

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  10 in total

1.  Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).

Authors:  T Takenaka; S Usuda; T Nomura; H Maeno; T Sado
Journal:  Arzneimittelforschung       Date:  1976

2.  Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.

Authors:  N Sakamoto; M Terai; T Takenaka; H Maeno
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

3.  Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.

Authors:  K Satoh; T Yanagisawa; N Taira
Journal:  Clin Exp Pharmacol Physiol       Date:  1980 May-Jun       Impact factor: 2.557

4.  Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs.

Authors:  H Yasue; S Omote; A Takizawa; M Nagao; K Miwa; S Tanaka
Journal:  Am J Cardiol       Date:  1979-03       Impact factor: 2.778

5.  Nicorandil releases acetylcholine-induced sustained coronary arterial constriction in monkeys and baboons.

Authors:  K Satoh; M Maruyama; S Yamashita; N Taira
Journal:  Jpn Heart J       Date:  1984-03

6.  Comparison of the responses of the simian and canine coronary circulations to autonomic drugs.

Authors:  K Satoh; S Yamashita; M Maruyama; N Taira
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

7.  Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.

Authors:  R P Hof
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

8.  Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93).

Authors:  M Terai; T Takenaka; H Maeno
Journal:  Biochem Pharmacol       Date:  1981-02-15       Impact factor: 5.858

9.  Sustained coronary constriction and its antagonism by calcium-blocking agents in monkeys and baboons.

Authors:  N Taira; K Satoh; M Maruyama; S Yamashita
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

10.  Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.

Authors:  H Nakaya; M Kanno
Journal:  Arzneimittelforschung       Date:  1982
  10 in total
  1 in total

Review 1.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.